Taking a Stand: How ASCO Develops Policy Guidance and Position Statements
A global thought leader in the spheres of cancer care and research, ASCO takes a position on certain key issues affecting its members and the patients they serve.
FEATURED BLOGS
Feb 14, 2019
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Feb 14, 2019
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as...
Feb 04, 2019
A recent study should serve as a wake-up call to all Americans that obesity is linked to an increased risk of common cancers.
Feb 01, 2019
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.
Feb 01, 2019
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Jan 29, 2019
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
Advertisement
Latest Comments & Discussions
Feb 20, 2019
Case Summary – Oncology
Diffuse large B-cell lymphoma (DLBCL) is commonly cured with immuno-chemotherapy; however, high-...
Anonymous
Feb 20, 2019
Case Summary – Pathology (Dr. Kovach)
The revised 2016 WHO Classification of Lymphoid Neoplasms distinguishes diffuse large...
Jason R. Westin, MD
Feb 18, 2019
Course Faculty Response
Early relapse of diffuse large B-cell lymphoma implies a poor prognosis with an increased chance of chemotherapy...
ASCO University
Feb 18, 2019
Course Faculty Response (Dr. Alexandra Kovach)
Biopsy of an accessible lymph node to confirm relapse is highly suggested. The unlikely...
ASCO University
Feb 11, 2019
Discussion Questions
1. What additional pathology testing, on tumor or blood, would be potentially useful?
2. What treatment options...
Pages
Most Read
Clinical trials, a vital aspect of cancer research, can result in new, effective treatments that can help people with cancer live longer, healthier lives. So why is the participation so low?
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Immunotherapy—particularly immune checkpoint inhibition—is still experimental. It ends up being quite a difficult discussion for some who had hoped that they could stave off chemotherapy.
On February 3, Dr. Stephanie Graff hopes women in every aspect of medicine will feel inspired to choose themselves, and make their own wellness a priority.
Dr. Evangelia Razis will speak out about cancer and fight against the guilt and shame that attend a cancer diagnosis.
Jason R. Westin, MD